U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756528) titled 'Stakeholder-Informed RSV Prevention Economic Model in Botswana' on Aug. 06.
Brief Summary: The goal of this mixed methods study is to engage stakeholders to develop a health economic model to estimate the costs, health benefits, and value of respiratory syncytial virus (RSV) prevention strategies. The model will help decision-makers in Botswana determine whether and how to introduce RSV prevention interventions for infants, including monoclonal antibodies.
The main questions the study aims to answer are:
How could RSV prevention strategies be delivered to infants in Botswana?
What costs, health benefits, and implementation factor...